BriaCell Therapeutics Corp.
BCTX · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $20,723 | $14,054 | $83,302 | $135,518 |
| - Cash | $2,714 | $10,472 | $17,215 | $7,389 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $18,009 | $3,582 | $66,087 | $128,129 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$37 | -$36 | -$38 | -$38 |
| % Margin | – | – | – | – |
| EBITDA | -$11,450 | -$11,120 | -$8,766 | -$9,091 |
| % Margin | – | – | – | – |
| Net Income | -$11,375 | -$11,057 | -$8,717 | -$9,063 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.31 | -5.87 | -23.33 | -33.57 |
| % Growth | 26.6% | 74.8% | 30.5% | – |
| Operating Cash Flow | -$10,691 | -$11,204 | -$10,105 | -$8,551 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$10,691 | -$11,204 | -$10,105 | -$8,551 |